Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04351087 · ClinicalTrials.gov registry record · NA
Microfragmented Adipose Tissue Versus Platelet-rich Plasma for Knee Osteoarthritis: a Randomized Comparative Trial
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT04351087: Completed NA study, sponsored by Ohio State University.
NCT04351087 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 79 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04351087, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
The study aims to conduct a randomized trial comparing the clinical outcomes of PRP (standard intervention) versus Microfragmented adipose tissue (investigational) for the treatment of knee osteoarthritis. Hypothesis: Both interventions will result in significant improvement in patient-reported outcomes. We hypothesize that Microfragmented adipose tissue will provide superior outcomes.
Primary Outcome
The Knee injury and Osteoarthritis Outcome Pain Score \[KOOS questionnaire\] is a self-reported outcome measure assessing the patient's opinion about the pain in their knee. Standardized answer options are given \[5 Likert boxes\] and each question is assigned a score from 0 to 4. A normalized score \[100 indicating no pain and 0 indicating extreme pain\] is calculated.
Interventions
- DEVICE Platelet Rich Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2020-03-03 |
| Est. Completion | 2022-07-05 |
| Phase | NA |
What the finished NCT04351087 record still lists
NCT04351087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Platelet Rich Plasma is the first listed.
NCT04351087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04351087 about?
NCT04351087 is a clinical study titled "Microfragmented Adipose Tissue Versus Platelet-rich Plasma for Knee Osteoarthritis: a Randomized Comparative Trial". The study aims to conduct a randomized trial comparing the clinical outcomes of PRP (standard intervention) versus Microfragmented adipose tissue (investigational) for the treatment of knee osteoarthritis. Hypothesis: Both interventions will result in significant improvement in patient-reported out...
What is the current status of trial NCT04351087?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2020-03-03. Estimated completion is 2022-07-05.
What interventions are being tested in trial NCT04351087?
The interventions under investigation include: Platelet Rich Plasma (DEVICE).
Who is sponsoring clinical trial NCT04351087?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04351087's enrollment target sits among peer trials
79 1060th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI